Adoptive Tumor-infiltrating Lymphocyte Transfer With Nivolumab for Melanoma
Clinical trial NCT04165967 · COMPLETED
Trial details
- NCT number
- NCT04165967
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-17
- Primary completion
- 2023-03-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.